Brookmont Capital Management Johnson & Johnson Transaction History

Brookmont Capital Management

$194 Million
Q3 2024

A detailed history of Brookmont Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Brookmont Capital Management holds 14,591 shares of JNJ stock, worth $2.27 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

14,591

Previous 14,866 1.85%

Holding current value

$2.27 Million

Previous $2.17 Million 8.84%

% of portfolio

1.22%

Previous 1.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$145.48 - $167.38 $40,007 - $46,029	-275 Reduced 1.85%	14,591 $2.36 Million
Q2 2024 Jul 17, 2024	SELL	$144.38 - $157.78 $26,132 - $28,558	-181 Reduced 1.2%	14,866 $2.17 Million
Q1 2024 Apr 16, 2024	BUY	$155.22 - $162.74 $30,267 - $31,734	195 Added 1.31%	15,047 $2.38 Million
Q4 2023 Jan 18, 2024	BUY	$145.6 - $158.88 $9,318 - $10,168	64 Added 0.43%	14,852 $2.33 Million
Q3 2023 Oct 12, 2023	SELL	$155.75 - $174.48 $13,238 - $14,830	-85 Reduced 0.57%	14,788 $2.3 Million
Q2 2023 Jul 13, 2023	SELL	$154.35 - $166.11 $1,080 - $1,162	-7 Reduced 0.05%	14,873 $2.46 Million
Q1 2023 Apr 11, 2023	BUY	$151.05 - $180.26 $4,531 - $5,407	30 Added 0.2%	14,880 $2.31 Million
Q4 2022 Feb 06, 2023	SELL	$160.2 - $179.79 $78,818 - $88,456	-492 Reduced 3.21%	14,850 $2.62 Million
Q3 2022 Oct 12, 2022	BUY	$161.33 - $179.52 $151,488 - $168,569	939 Added 6.52%	15,342 $2.51 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $83,085 - $91,888	-494 Reduced 3.32%	14,403 $2.56 Million
Q1 2022 May 09, 2022	BUY	$158.14 - $179.59 $27,832 - $31,607	176 Added 1.2%	14,897 $2.64 Million
Q4 2021 Jan 27, 2022	SELL	$155.93 - $173.01 $95,117 - $105,536	-610 Reduced 3.98%	14,721 $2.52 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $15,988 - $17,767	99 Added 0.65%	15,331 $2.48 Million
Q2 2021 Jul 19, 2021	SELL	$159.48 - $171.07 $1,594 - $1,710	-10 Reduced 0.07%	15,232 $2.51 Million
Q1 2021 Apr 15, 2021	SELL	$153.07 - $170.48 $38,573 - $42,960	-252 Reduced 1.63%	15,242 $2.51 Million
Q4 2020 Feb 04, 2021	SELL	$137.11 - $157.38 $86,653 - $99,464	-632 Reduced 3.92%	15,494 $2.44 Million
Q3 2020 Oct 16, 2020	BUY	$140.38 - $153.83 $40,289 - $44,149	287 Added 1.81%	16,126 $2.4 Million
Q2 2020 Jul 23, 2020	SELL	$128.81 - $155.51 $522,324 - $630,593	-4,055 Reduced 20.38%	15,839 $2.23 Million
Q1 2020 Apr 28, 2020	SELL	$111.14 - $153.99 $85,800 - $118,880	-772 Reduced 3.74%	19,894 $2.61 Million
Q4 2019 Jan 22, 2020	SELL	$127.5 - $146.44 $224,017 - $257,295	-1,757 Reduced 7.84%	20,666 $3.02 Million
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $22,470 - $25,158	-177 Reduced 0.78%	22,423 $2.9 Million
Q2 2019 Jul 18, 2019	BUY	$131.15 - $144.24 $19,016 - $20,914	145 Added 0.65%	22,600 $3.15 Million
Q1 2019 Apr 16, 2019	BUY	$125.72 - $139.79 $4,651 - $5,172	37 Added 0.17%	22,455 $3.14 Million
Q4 2018 Feb 12, 2019	BUY	$122.84 - $147.84 $140,160 - $168,685	1,141 Added 5.36%	22,418 $2.89 Million
Q3 2018 Nov 08, 2018	BUY	$121.58 - $142.88 $15,683 - $18,431	129 Added 0.61%	21,277 $2.94 Million
Q2 2018 Jul 19, 2018	BUY	$119.4 - $131.76 $31,999 - $35,311	268 Added 1.28%	21,148 $2.57 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $2.6 Million - $3.08 Million	-20,776 Reduced 49.88%	20,880 $2.68 Million
Q4 2017 Feb 12, 2018	BUY	$131.22 - $143.62 $1.75 Million - $1.91 Million	13,320 Added 47.01%	41,656 $5.82 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $3.67 Million - $3.84 Million	28,336	28,336 $3.68 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $407B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookmont Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookmont Capital Management with notifications on news.

Account

Brookmont Capital Management Johnson & Johnson Transaction History